News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
567,076 Results
Type
Article (45723)
Company Profile (121)
Press Release (521232)
Multimedia
Podcasts (84)
Webinars (12)
Section
Business (155448)
Career Advice (2412)
Deals (29037)
Drug Delivery (120)
Drug Development (71306)
Employer Resources (151)
FDA (15856)
Job Trends (12485)
News (279004)
Policy (30557)
Tag
Academia (2369)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (84)
Alliances (37013)
ALS (95)
Alzheimer's disease (1459)
Antibody-drug conjugate (ADC) (145)
Approvals (15801)
Artificial intelligence (254)
Autoimmune disease (27)
Automation (13)
Bankruptcy (318)
Best Places to Work (9663)
BIOSECURE Act (22)
Biosimilars (115)
Biotechnology (73)
Bladder cancer (81)
Brain cancer (27)
Breast cancer (279)
Cancer (2231)
Cardiovascular disease (195)
Career advice (2016)
Career pathing (33)
CAR-T (146)
Cell therapy (427)
Cervical cancer (21)
Clinical research (58068)
Collaboration (746)
Company closure (2)
Compensation (566)
Complete response letters (29)
COVID-19 (2645)
CRISPR (45)
C-suite (234)
Cystic fibrosis (99)
Data (2181)
Decentralized trials (2)
Denatured (15)
Depression (54)
Diabetes (277)
Diagnostics (5495)
Digital health (16)
Diversity (4)
Diversity, equity & inclusion (42)
Drug discovery (104)
Drug pricing (126)
Drug shortages (30)
Duchenne muscular dystrophy (100)
Earnings (66778)
Editorial (47)
Employer branding (20)
Employer resources (136)
Events (92040)
Executive appointments (674)
FDA (17205)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (669)
Gene editing (110)
Generative AI (22)
Gene therapy (329)
GLP-1 (810)
Government (4158)
Grass and pollen (6)
Guidances (152)
Healthcare (15614)
Huntington's disease (25)
IgA nephropathy (29)
Immunology and inflammation (148)
Indications (26)
Infectious disease (2795)
Inflammatory bowel disease (140)
Inflation Reduction Act (9)
Influenza (51)
Intellectual property (91)
Interviews (451)
IPO (14576)
IRA (48)
Job creations (3204)
Job search strategy (1672)
Kidney cancer (11)
Labor market (37)
Layoffs (523)
Leadership (23)
Legal (7185)
Liver cancer (74)
Lung cancer (314)
Lymphoma (152)
Machine learning (9)
Management (51)
Manufacturing (315)
MASH (80)
Medical device (11607)
Medtech (11610)
Mergers & acquisitions (14997)
Metabolic disorders (759)
Multiple sclerosis (82)
NASH (22)
Neurodegenerative disease (106)
Neuropsychiatric disorders (33)
Neuroscience (2020)
NextGen: Class of 2025 (5205)
Non-profit (3376)
Now hiring (19)
Obesity (415)
Opinion (225)
Ovarian cancer (74)
Pain (95)
Pancreatic cancer (82)
Parkinson's disease (152)
Partnered (16)
Patents (238)
Patient recruitment (104)
Peanut (45)
People (44291)
Pharmaceutical (35)
Pharmacy benefit managers (22)
Phase I (17232)
Phase II (25251)
Phase III (20546)
Pipeline (1346)
Policy (177)
Postmarket research (2377)
Preclinical (7153)
Press Release (37)
Prostate cancer (111)
Psychedelics (36)
Radiopharmaceuticals (223)
Rare diseases (407)
Real estate (4409)
Recruiting (60)
Regulatory (21450)
Reports (33)
Research institute (2101)
Resumes & cover letters (402)
Rett syndrome (5)
RNA editing (3)
RSV (47)
Schizophrenia (78)
Series A (123)
Series B (82)
Service/supplier (10)
Sickle cell disease (55)
Special edition (18)
Spinal muscular atrophy (132)
Sponsored (33)
Startups (2826)
State (1)
Stomach cancer (16)
Supply chain (72)
Tariffs (54)
The Weekly (68)
Vaccines (781)
Venture capitalists (44)
Weight loss (298)
Women's health (32)
Worklife (20)
Date
Today (58)
Last 7 days (927)
Last 30 days (2882)
Last 365 days (30221)
2025 (11253)
2024 (32370)
2023 (36361)
2022 (46517)
2021 (50204)
2020 (47189)
2019 (38128)
2018 (28869)
2017 (28815)
2016 (27346)
2015 (30613)
2014 (24114)
2013 (19571)
2012 (21043)
2011 (21512)
2010 (19456)
Location
Africa (682)
Alabama (48)
Alaska (6)
Arizona (180)
Arkansas (10)
Asia (32442)
Australia (5673)
California (5963)
Canada (1657)
China (446)
Colorado (248)
Connecticut (275)
Delaware (143)
Europe (78766)
Florida (890)
Georgia (195)
Hawaii (1)
Idaho (39)
Illinois (471)
India (24)
Indiana (269)
Iowa (11)
Japan (156)
Kansas (86)
Kentucky (14)
Louisiana (7)
Maine (62)
Maryland (878)
Massachusetts (4462)
Michigan (192)
Minnesota (355)
Mississippi (1)
Missouri (73)
Montana (12)
Nebraska (19)
Nevada (60)
New Hampshire (53)
New Jersey (1677)
New Mexico (15)
New York (1649)
North Carolina (939)
North Dakota (6)
Northern California (2665)
Ohio (168)
Oklahoma (8)
Oregon (28)
Pennsylvania (1287)
Puerto Rico (10)
Rhode Island (21)
South America (1049)
South Carolina (23)
South Dakota (1)
Southern California (2251)
Tennessee (91)
Texas (834)
United States (22025)
Utah (168)
Virginia (141)
Washington D.C. (63)
Washington State (524)
West Virginia (3)
Wisconsin (57)
567,076 Results for "molmed s p a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Inspire Medical Systems, Inc. Announces the Addition of Paul T. Hoff, M.D., M.S. and Ruchir P. Patel, M.D., F.A.C.P. as Vice President, Senior Medical Directors
April 21, 2025
·
4 min read
Press Releases
David P. King Joins Truvian’s Advisory Board
January 13, 2025
·
2 min read
Press Releases
Acadia Pharmaceuticals Set to Join S&P SmallCap 600
December 31, 2024
·
1 min read
Press Releases
Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A
January 14, 2025
·
4 min read
Press Releases
Priothera Appoints Dr. Jens Hasskarl as Chief Medical Officer to Drive Late-Stage Clinical Development of Mocravimod, a S1P Receptor Modulator for Acute Myeloid Leukemia (AML)
May 6, 2025
·
3 min read
Press Releases
Bruker Introduces nVista 2P Miniature Microscope
April 17, 2025
·
3 min read
Deals
MolMed S.p.A Becomes AGC Biologics S.p.A Following the July Acquisition
After its parent company AGC Inc. acquired 100% of the shares of MolMed S.p.A. on September 30, 2020, AGC Biologics announced that MolMed’s entity name has been changed to AGC Biologics S.p.A.
October 27, 2020
·
2 min read
Press Releases
Azafaros to Present at J.P. Morgan’s 43rd Annual Healthcare Conference
January 9, 2025
·
3 min read
Press Releases
Axxam S.p.A. accelerates global expansion incorporating Axxam Inc.
December 13, 2024
·
2 min read
Press Releases
Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ’s Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor Fitzgerald
April 30, 2025
·
1 min read
1 of 56,708
Next
